Markel Group Portfolio in 2026: Top Holdings & Recent Changes
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Tom Gayner, CEO of Markel Group, showcases his disciplined approach to long-term value investing through the firm's latest 13F filing. The $12.5B portfolio for Q4 2025 emphasizes stability in core positions while making selective additions in high-conviction names like Brookfield Corporation (BN), signaling confidence in resilient businesses amid market volatility.
Portfolio Snapshot: Disciplined Diversification with a Quality Core
Portfolio Highlights (Q4 2025): - Market Value: $12.5B - Top 10 Holdings: 42.0% - Portfolio Size: 128 -1 - Average Holding Period: 30 quarters - Turnover: 2.3%
Markel Group's portfolio reflects a balanced strategy, with the top 10 holdings commanding 42% of assets despite a broad 128-position lineup—a slight trim from the prior quarter. This structure highlights Gayner's preference for meaningful exposure to elite businesses without over-concentration, allowing flexibility across sectors while prioritizing long-term holders. The ultra-low 2.3% turnover and 30-quarter average holding period underscore a buy-and-hold philosophy, akin to the "Berkshire of insurance" moniker often applied to Markel.
The image above illustrates this allocation, showing heavy weighting toward technology and financials, with emerging bets in industrials and healthcare. At $12.5B, the portfolio's scale enables significant positions without liquidity issues, and the single-position reduction suggests ongoing portfolio hygiene. Investors tracking Markel Group's moves via 13F filings will note this as a period of refinement rather than revolution, maintaining conviction in proven compounders.
Key Positions: Strategic Adds Amid Core Stability
Markel Group's portfolio pivots around standout changes, starting with a bold Brookfield Corporation (BN) at 4.8% after Add 50.00%, vaulting it into the top five and signaling strong belief in its asset management prowess. Beyond the top tier, Analog Devices (ADI) holds 2.2% following a Reduce 12.37% trim, while Microsoft (MSFT) at 2.1% saw a modest Add 0.68%, reinforcing tech exposure.
Lower in the ranks, additions continue with LPL Financial (LPLA) (1.6%, Add 1.20%), Watsco (WSO) (1.6%, Add 2.21%), and American Express (AXP) (1.4%, Add 0.88%), diversifying into financial services and distribution. Lowe's (LOW) (1.4%, Add 1.07%) and Novo Nordisk (NVO) (1.2%, Add 21.16%) highlight home improvement and healthcare conviction, while reductions in Meta Platforms (META) (1.3%, Reduce 11.41%) and an add in Franco-Nevada (FNV) (1.1%, Add 12.88%) balance growth with commodities.
Core top holdings remain anchors: Alphabet (GOOG) leads at 6.9% (No change), followed by Berkshire Hathaway (BRK-A) (6.7%, No change), BRK-B (6.1%, No change), Amazon (AMZN) (3.7%, No change), Deere (DE) (3.3%, No change), Visa (V) (2.8%, No change), Apple (AAPL) (2.7%, No change), Home Depot (HD) (2.5%, No change), and Goldman Sachs (GS) (2.5%, No change). These moves blend opportunistic tweaks with unwavering faith in quality names.
What the Portfolio Reveals About Markel’s Strategy
Markel Group's Q4 actions reveal a strategy centered on quality compounders with economic moats, favoring businesses with durable cash flows over speculative growth. Heavy tech weighting (Alphabet, Amazon, Microsoft, Apple, Meta) at over 20% of top holdings shows comfort with innovation leaders, balanced by financial stalwarts like Berkshire, Visa, AXP, and GS.
- Sector Focus: Technology and financials dominate (top 10 skews ~40% combined), with tactical adds in healthcare (NVO) and commodities (FNV) for diversification.
- Geographic Concentration: Primarily U.S.-centric, with international flavor via Brookfield and Novo Nordisk.
- Risk Management: Low turnover 2.3% and broad 128 holdings mitigate volatility, while top-10 concentration 42% amplifies winners.
- Quality Over Growth: Additions like Deere, Watsco, and LPL emphasize resilient industrials and services, avoiding high-beta plays.
Trims in ADI and Meta suggest profit-taking on prior winners, preserving dry powder for asymmetric opportunities.
Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.
Want to see what we'll uncover next - before everyone else does?
Find Hidden Gems First!
Portfolio Concentration Analysis
| Position | Value | % of Portfolio | Recent Change |
|---|---|---|---|
| Alphabet Inc. (GOOG) | $862.9M | 6.9% | No change |
| Berkshire Hathaway Inc. (BRK-A) (BRK-A) | $840.8M | 6.7% | No change |
| Berkshire Hathaway Inc. (BRK-B) (BRK-B) | $770.0M | 6.1% | No change |
| Brookfield Corporation (BN) | $599.9M | 4.8% | Add 50.00% |
| Amazon.com, Inc. (AMZN) | $468.7M | 3.7% | No change |
| Deere & Company (DE) | $408.7M | 3.3% | No change |
| Visa Inc. (V) | $350.5M | 2.8% | No change |
| Apple Inc. (AAPL) | $333.7M | 2.7% | No change |
| The Home Depot, Inc. (HD) | $316.6M | 2.5% | No change |
| The Goldman Sachs Group, Inc. (GS) | $315.9M | 2.5% | No change |
This top-10 table underscores Markel Group's measured concentration: no single position exceeds 7%, yet the group represents 42% of the $12.5B portfolio, enabling focused bets without excessive risk. The sole major change—Brookfield's 50% add—elevates it to fourth place, displacing prior holdings and highlighting Gayner's willingness to double down on perceived value in alternative assets. Stability in Berkshire duo (12.8% combined) and tech giants reflects "forever" holdings, while the even sizing (mostly 2.5-6.9%) promotes diversification within conviction.
Investment Lessons from Tom Gayner’s Markel Approach
- Patience Pays: 30-Quarter Holding Periods: Gayner's average tenure demonstrates that true value emerges over decades, not quarters—exemplified by unchanged core like Alphabet and Berkshire.
- Quality Moats Trump Valuations: Holdings like Visa, Apple, and Deere prioritize unbeatable competitive advantages, even at premiums, over cheap cyclicals.
- Selective Concentration in a Diverse Portfolio: 42% in top 10 across 128 names balances bold sizing (e.g., BN add) with broad risk spreading.
- Opportunistic Tweaks, Not Overtrading: 2.3% turnover shows discipline—adds like NVO 21% target undervalued growth, trims like META lock in gains.
- Insurance Mindset for Equity Investing: Mirror Markel's float-like patience, using low turnover to compound without forced selling.
Track Markel Group on ValueSense for real-time 13F insights.
Looking Ahead: What Comes Next?
With turnover at a scant 2.3% and a one-position trim, Markel maintains ample dry powder within its $12.5B book for opportunistic deploys. The Brookfield surge and healthcare/commodities adds (NVO, FNV) position the portfolio for inflation hedges and global recovery plays. Tech anchors like GOOG and MSFT set up for AI tailwinds, while financials (AXP, LPL) benefit from rate normalization.
In 2026's uncertain markets—potential recessions or tech rotations—Markel's quality tilt offers downside protection via moats and dividends. Watch for further industrials/distribution builds (WSO, LOW, DE) if economic softening creates entry points. Gayner's track record suggests measured expansion in undervalued sectors, trackable via ValueSense 13F alerts.
FAQ about Markel Group Portfolio
Q: What’s the biggest change in Markel Group's Q4 2025 13F?
A: The standout move is Add 50.00% to Brookfield (BN) at 4.8% $599.9M, jumping to #4. Other notables include Add 21.16% to Novo Nordisk (NVO) and trims in ADI -12.37% and META -11.41%.
Q: Why is Markel Group's portfolio so broadly diversified yet top-10 heavy?
A: At 128 positions with 42% in the top 10, it balances conviction (e.g., 6.9% GOOG) with risk control, allowing satellite bets while amplifying winners—classic Gayner style for long-term compounding.
Q: How does Tom Gayner’s leadership influence the strategy?
A: As CEO since 2005, Gayner instills a Berkshire-inspired culture: low turnover 2.3%, 30-quarter holds, and quality focus, evolving Markel into a permanent capital vehicle for patient equity ownership.
Q: Which sectors stand out in the holdings?
A: Technology (~25% via GOOG, AMZN, AAPL, MSFT, META), financials (BRK, V, GS, AXP, LPL), and emerging industrials/healthcare (DE, WSO, LOW, NVO)—a moat-heavy mix for resilience.
Q: How can I track Markel Group’s portfolio like a pro?
A: Use ValueSense's superinvestor tracker at valuesense.io/superinvestors/markel-group for instant 13F updates. Note the 45-day filing lag means Q4 data reflects year-end 2025 moves—perfect for following without the noise.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2026)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!